johnson and johnson - Tech News from Simmons Systems

Tech News from Simmons Systems

johnson and johnson

A collection of 10 posts

Nvidia Targets Healthcare Industry With New AI Partnerships and Tools

Nvidia expands into the healthcare sector through new partnerships with Johnson & Johnson and GE Healthcare, alongside the launch of two dozen AI-powered medical tools. Industry experts note that generative AI offers tangible benefits for drug discovery and medical technology.

johnson and johnson

Federal Officials Extend Pause on Johnson & Johnson Vaccine Over Rare Clotting Cases

U.S. regulators and an independent expert panel extend a pause on the Johnson & Johnson vaccine after six women develop rare blood clots. Health officials warn the delay leaves vulnerable populations at risk while the White House downplays the impact on overall vaccination goals.

johnson and johnson

CDC Panel Delays Decision on Johnson & Johnson Vaccine Amid Blood Clot Concerns

U.S. health officials keep the Johnson & Johnson COVID-19 vaccine on pause after an advisory committee requests more time to review rare but severe blood clot cases. The experts plan to reconvene within 10 days to issue a formal recommendation.

johnson and johnson

Federal Panel Delays Decision on Johnson & Johnson Vaccine Pause

U.S. health officials extend the pause on the Johnson & Johnson COVID-19 vaccine as an advisory committee requests more time to review rare blood clot cases. The group plans to reconvene within 10 days to issue a formal recommendation.

FDA and CDC Officials Announce Temporary Pause on Johnson and Johnson Vaccine

Federal health agencies issue a temporary halt to the Johnson and Johnson COVID-19 vaccine as they investigate rare blood clot cases. Officials urge the public to remain calm and monitor for symptoms while the review takes place.

johnson and johnson

CDC Panel Extends Johnson & Johnson Vaccine Pause Amid Blood Clot Probe

A CDC advisory committee keeps the Johnson & Johnson Covid-19 vaccine on hold while experts gather more data on rare but severe blood clot risks. The panel plans to reconvene in a week to make a final recommendation.

FDA Approves First Major Depression Drug in Over 30 Years

The FDA approves Johnson & Johnson's Spravato, an esketamine nasal spray for treatment-resistant depression. The fast-acting medication brings the first major breakthrough in depression treatment since the introduction of Prozac.

FDA Approves Esketamine Nasal Spray for Hard-to-Treat Depression

The FDA approves esketamine, a ketamine-related nasal spray, offering a fast-acting new option for patients with treatment-resistant depression. The Johnson & Johnson drug marks the first major depression treatment to reach the U.S. market in decades.

johnson and johnson

Johnson & Johnson Buys Auris Health for $3.4 Billion to Expand Robotic Surgery

Johnson & Johnson's Ethicon division acquires robotic surgery startup Auris Health for $3.4 billion in cash to enhance its lung cancer diagnostics and treatment capabilities.

J&J's $818 Million Bet Unlocks New Path for CRISPR Therapies

Johnson & Johnson strikes an up to $818 million deal with Locus Biosciences to develop a unique CRISPR technology that destroys harmful bacterial DNA instead of editing it. The partnership focuses on treating respiratory and other organ infections while preserving the patient's healthy microbiome.